Structure Therapeutics (GPCR) Non-Current Assets (2022 - 2026)

Quarterly Non-Current Assets rose 3.54% to $17.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $66.4 million through Mar 2026, up 38.32% year-over-year, with the annual reading at $13.6 million for FY2025, 12.34% up from the prior year.

Structure Therapeutics' Non-Current Assets history spans 5 years, with the latest figure at $17.5 million for Q1 2026.

  • Non-Current Assets came in at $17.5 million for Q1 2026, up from $13.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $18.1 million in Q3 2025 to a low of $1.2 million in Q1 2023.
  • The 5-year median for Non-Current Assets is $9.5 million (2024), against an average of $10.3 million.
  • Year-over-year, Non-Current Assets surged 680.1% in 2024 and then rose 3.54% in 2026.
  • Structure Therapeutics' Non-Current Assets stood at $4.8 million in 2022, then skyrocketed by 76.81% to $8.4 million in 2023, then skyrocketed by 44.12% to $12.1 million in 2024, then rose by 12.34% to $13.6 million in 2025, then rose by 28.73% to $17.5 million in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Non-Current Assets are $17.5 million (Q1 2026), $13.6 million (Q4 2025), and $18.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 4.56 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 62,953.78
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 5.83 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 14.75 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 22.66 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 910.24 Mn
10 Structure Therapeutics 8.43 Bn 8.43 Bn - 17.53 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.53 Mn
Dec 31, 2025 13.62 Mn
Sep 30, 2025 18.14 Mn
Jun 30, 2025 17.15 Mn
Mar 31, 2025 16.93 Mn
Dec 31, 2024 12.12 Mn
Sep 30, 2024 9.57 Mn
Jun 30, 2024 9.41 Mn
Mar 31, 2024 7.87 Mn
Dec 31, 2023 8.41 Mn
Sep 30, 2023 6.41 Mn
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.20 Mn
Dec 31, 2022 4.76 Mn